[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Apixaban Market Analysis by Grade, Forms & Application, Trends, Share & Challenges Analysis & Industry Forecast (2017-2022)

September 2017 | 102 pages | ID: GD2270FE348EN
SPER Market Research

US$ 3,100.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT DESCRIPTION

This report represents the global and regional analysis of Apixaban in terms of Dosage, Strength, API, application Wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent Wise (North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa) manufacturer & buyers also.

Apixaban Introduction

“Apixaban” is White to pale yellow powder which is soluble in water, act as an oral anticoagulant drug used in the treatment of thromboembolic diseases, developed by Pfizer & Bristol Mayer Squibb. It is marketed by the name of eliquis, available in the form of tablet with varying strength. In case of post-orthopedic surgical procedures it is used to lower the risk of developing venous thrombosis. Apixaban mechanism act by inhibiting coagulation which prevents development of blood clot. If administered orally, the half-life is 12 hours (due to prolonged absorption). If administered by I.V., the half-life is about 5 hours

REPORT HIGHLIGHTS
  • Provide manufacturing capacity, consumption, current & past status & also the forecasting upto 2022.
  • Provide complete overview including type, application & forecast region.
  • Provide complete analysis of API & formulation including brand names, strength & market overview.
  • Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
  • Historical, current and projected market size in terms of volume and value.
  • Analyze the global & regional potential market, advantages, risk & opportunity.
  • Identify significant trends and factors driving or inhibiting the market growth.
  • In-depth coverage of complete market in terms of supplier, buyer, price, trend, growth & forecasting.
The report covers exhaustive analysis on;
  • Market Segments
  • Market Dynamics
  • Brands In Market
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Forecasting
  • Technology
The report includes Regional analysis on;
  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Europe (Germany, Italy, France, U.K, Spain & Rest of Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, North Africa & Rest of MEA)
Top Players in Apixaban industry
  • Bristol-Myers Squibb
  • Pfizer
  • Polpharma
  • Centaur Pharmaceutical
  • Beijing Cooperate Pharmaceutical
  • Boehringer Ingelheim
  • Abbott India Ltd
  • Teva Pharmaceutical Industries Ltd
  • Bayer Healthcare AG
  • Mitsubishi Tanabe Pharma Co
Key Questions answered by report
  • What was the market size trend of 2014-2016?
  • What will be the market size trend of next 4-5 years?
  • What are the most common brands in terms of volume?
  • How much brands available for Apixaban?
  • Whare the key players of Apixaban API?
  • What are the major application industries & emerging industries?
  • Whare the key vendors present in the market?
  • How the future opportunities & market drivers will affect the market dynamics & ongoing trends?
  • Which one segment from global coverage will be lucrative & will grow?
  • What are the main market opportunities and threats faced by the vendors?
  • What are the strategies are following by the existing market players
CHAPTER 1 RESEARCH METHODOLOGY

CHAPTER 2 REPORT DESCRIPTION

CHAPTER 3 APIXABAN EXECUTIVE SUMMARY

CHAPTER 4 APIXABAN BASIC HIGHLIGHTS

4.1. Product Overview
4.2. CAS No & Molecular Weight
4.3. Innovator Details
4.4. Priority & Patent Expiry
4.5. Molecular Formula
4.6. Market Status

CHAPTER 5 GLOBAL APIXABAN PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY

5.1. Apixaban Forms (Anhydrous or Monohydrate)
5.2. Apixaban Grades Description
5.3. Apixaban Route of Administration
5.4. Apixaban Synonym
  5.5.1. Apixaban Applications

CHAPTER 6 APIXABAN MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM

6.1. Apixaban Manufacturing Process Routes & Flow Chart
6.2. Apixaban Upstream & Downstream Products

CHAPTER 7 APIXABAN BRAND LIST & MECHANISM OF ACTION

7.1. Apixaban All Global Brands
7.2. Apixaban Dosage & Their Strengths
7.3. Apixaban Mechanism of Action

CHAPTER 8 APIXABAN (FORMULATION) REGION WISE MARKET OVERVIEW

8.1. Apixaban Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
8.2. Apixaban Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
8.3. Apixaban Market Overview In North America (Canada, US & Rest of North America Available)
8.4. Apixaban Market Overview In South America (Brazil, Argentina & Rest of South America Available)
8.5. Apixaban Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

CHAPTER 9 APIXABAN (API) REGION WISE MARKET OVERVIEW

9.1. Apixaban Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
9.2. Apixaban Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
9.3. Apixaban Market Overview In North America (Canada, US & Rest of North America Available)
9.4. Apixaban Market Overview In South America (Brazil, Argentina & Rest of South America Available)
9.5. Apixaban Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

CHAPTER 10 APIXABAN (API & FORMULATION) CONTINENT & COUNTRY WISE MANUFACTURERS, MANUFACTURING VOLUME & CONTACT OVERVIEW

10.1. Apixaban Continent Wise Manufacturers
10.2. Apixaban Continent Wise Manufacturing Volume
10.3. Apixaban Country Wise Manufacturers
10.4. Apixaban Country Wise Manufacturing Volume
10.5. Apixaban Manufacturers Contact Overview

CHAPTER 11 APIXABAN GLOBAL PRICE TREND ANALYSIS OF LAST 3 YEARS

11.1. Apixaban Global Price Trend Analysis
11.2. Apixaban Country Wise Price Trend Analysis

CHAPTER 12 APIXABAN INTERNATIONAL MARKET OVERVIEW

12.1. Global Demand/ Supply & Global Prices
12.2. Major Destinations Involved In Trade
12.3. Major Manufacturers (Capacities & Prices)

CHAPTER 13 APIXABAN (FORMULATION) GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2017-2022) ANALYSIS

13.1. Apixaban Global Market Size (Past & Future Forecasting)
13.2. Apixaban Global Market Growth (Past & Future Forecasting)
13.3. Apixaban Continent Wise Market Size (Past & Future Forecasting)
13.4. Apixaban Continent Wise Market Growth (Past & Future Forecasting)

CHAPTER 14 APIXABAN (FORMULATION) CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW

14.1. Apixaban Global Consumers
14.2. Apixaban Global Consumers As Per Consumption Quantity
14.3. Apixaban Continent Wise Consumer
14.4. Apixaban Continent Wise Consumer As Per Consumption Quantity
14.5. Apixaban Country Wise Consumer
14.6. Apixaban Country Wise Consumer As Per Consumption Quantity
14.7. Apixaban Consumers Contact Overview

CHAPTER 15 APIXABAN CONTINENT WISE EXPORT/ IMPORT ANALYSIS

15.1. Apixaban Continent Wise Import Analysis
15.2. Apixaban Continent Wise Export Analysis
15.3. Apixaban Country Wise Import Analysis
15.4. Apixaban Country Wise Export Analysis

CHAPTER 16 APIXABAN WORLDWIDE SWOT ANALYSIS

16.1. Apixaban Strength Analysis
16.2. Apixaban Weakness Analysis
16.3. Apixaban Opportunity Analysis
16.4. Apixaban Threat Analysis

CHAPTER 17 APIXABAN REPORT BASED BUSINESS RECOMMENDATION


More Publications